BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/14/2020 12:30:24 PM | Browse: 869 | Download: 2349
 |
Received |
|
2019-12-24 11:05 |
|
Peer-Review Started |
|
2019-12-24 11:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-01-19 01:08 |
|
Revised |
|
2020-03-20 01:21 |
|
Second Decision |
|
2020-03-26 11:05 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-03-26 21:07 |
|
Articles in Press |
|
2020-03-26 21:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-04-13 10:18 |
|
Publish the Manuscript Online |
|
2020-04-14 12:30 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Robert Sean O'Neill, Sam Emmanuel, David Williams and Alina Stoita |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alina Stoita, FRACP, MBBS, Assistant Lecturer, Doctor, Doctor, Department of Gastroenterology, St Vincent’s Hospital Sydney, 390 Victoria Street, Sydney 2010, Australia. alina.stoita@svha.org.au |
| Key Words |
Growth differentiation factor 15; Cytokines; Pancreatic neoplasms; Digestive system neoplasms; Pancreatic diseases; Biomarkers |
| Core Tip |
In this prospective cohort study in an asymptomatic population at high risk of developing pancreatic cancer due to a genetic predisposition serum baseline macrophage inhibitory cytokine-1 or growth differentiation factor-15 was shown to be a significant predictor of neoplastic tumours (both pancreatic and extra-pancreatic). |
| Publish Date |
2020-04-14 12:30 |
| Citation |
O’Neill RS, Emmanuel S, Williams D, Stoita A. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort. World J Gastroenterol 2020; 26(14): 1660-1673 |
| URL |
https://www.wjgnet.com/2219-2840/full/v26/i14/1660.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i14.1660 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
